Canntab Therapeutics Limited
PILL
Kedudukan dalam Saham
#40499
Canntab Therapeutics Limited, a phytopharmaceutical firm with its main office... Canntab Therapeutics Limited, a phytopharmaceutical firm with its main office in Markham, Canada, is dedicated to the research and development of sophisticated, medical-grade cannabinoid compounds. The company's diverse portfolio within Canada includes various orally administered pharmaceutical cannabis products. These innovative dosage forms encompass extended-release cannabinoid pellets, rapid-onset cannabidiol options, multi-layered modified-release formulations, quickly dissolving flash-melt versions, and dual-layer cannabinoid tablets. Canntab's products are designed to address a wide spectrum of health concerns, such as sleep disturbances, post-traumatic stress disorder, social anxiety, different forms of addiction, arthritic conditions, general pain management, alleviating pain and stimulating appetite for cancer patients, and aiding in recovery from opioid and other painkiller dependencies.
Harga Saham
$0.0036163
Disegerakkan terakhir: 2023-10-30
Modal Pasaran
$118.21K
Perubahan (1 hari)
0.39%
Perubahan (1 tahun)
3,516.30%
Negara
CA
Perdagangan Canntab Therapeutics Limited (PILL)
Kategori
Healthcare
Modal pasaran bagi Canntab Therapeutics Limited(PILL)
Modal Pasaran: $118.21K
Sehingga October 2026, Canntab Therapeutics Limited mempunyai modal pasaran sebanyak $118.21K. Ini menjadikan Canntab Therapeutics Limited syarikat ke-40499th paling bernilai di dunia mengikut data kami. Kapitalisasi pasaran ialah nilai keseluruhan saham syarikat tersenarai yang berada dalam edaran dan lazimnya digunakan untuk menilai nilai syarikat tersebut.
Sejarah modal pasaran Canntab Therapeutics Limited dari 2017 hingga 2026
PILL berbanding dengan 5 teratas yang paling popular stocks
